(18)F-Flourodeoxy-Glucose PET/Computed Tomography in Brain Tumors: Value to Patient Management and Survival Outcomes.
Publication
, Journal Article
Wray, R; Solnes, L; Mena, E; Meoded, A; Subramaniam, RM
Published in: PET Clin
July 2015
(18)F-flourodeoxy-glucose (FDG) PET/computed tomography (CT) is most useful in the evaluation of primary central nervous system (CNS) lymphoma, important in diagnosis, pretherapy prognosis, and therapy response evaluation. Utility in working up gliomas is less effective, and FDG PET/CT is most helpful when MR imaging is unclear. FDG avidity correlates with the grade of gliomas. FDG PET/CT can be used to noninvasively identify malignant transformation. Establishing this change in the disease process has significant effects on patient management and survival outcome.
Duke Scholars
Published In
PET Clin
DOI
EISSN
1879-9809
Publication Date
July 2015
Volume
10
Issue
3
Start / End Page
423 / 430
Location
United States
Related Subject Headings
- Tomography, X-Ray Computed
- Radiopharmaceuticals
- Prognosis
- Precancerous Conditions
- Positron-Emission Tomography
- Nuclear Medicine & Medical Imaging
- Neoplasm Staging
- Neoplasm Recurrence, Local
- Multimodal Imaging
- Lymphoma
Citation
APA
Chicago
ICMJE
MLA
NLM
Wray, R., Solnes, L., Mena, E., Meoded, A., & Subramaniam, R. M. (2015). (18)F-Flourodeoxy-Glucose PET/Computed Tomography in Brain Tumors: Value to Patient Management and Survival Outcomes. PET Clin, 10(3), 423–430. https://doi.org/10.1016/j.cpet.2015.03.011
Wray, Rick, Lilja Solnes, Esther Mena, Avner Meoded, and Rathan M. Subramaniam. “(18)F-Flourodeoxy-Glucose PET/Computed Tomography in Brain Tumors: Value to Patient Management and Survival Outcomes.” PET Clin 10, no. 3 (July 2015): 423–30. https://doi.org/10.1016/j.cpet.2015.03.011.
Wray R, Solnes L, Mena E, Meoded A, Subramaniam RM. (18)F-Flourodeoxy-Glucose PET/Computed Tomography in Brain Tumors: Value to Patient Management and Survival Outcomes. PET Clin. 2015 Jul;10(3):423–30.
Wray, Rick, et al. “(18)F-Flourodeoxy-Glucose PET/Computed Tomography in Brain Tumors: Value to Patient Management and Survival Outcomes.” PET Clin, vol. 10, no. 3, July 2015, pp. 423–30. Pubmed, doi:10.1016/j.cpet.2015.03.011.
Wray R, Solnes L, Mena E, Meoded A, Subramaniam RM. (18)F-Flourodeoxy-Glucose PET/Computed Tomography in Brain Tumors: Value to Patient Management and Survival Outcomes. PET Clin. 2015 Jul;10(3):423–430.
Published In
PET Clin
DOI
EISSN
1879-9809
Publication Date
July 2015
Volume
10
Issue
3
Start / End Page
423 / 430
Location
United States
Related Subject Headings
- Tomography, X-Ray Computed
- Radiopharmaceuticals
- Prognosis
- Precancerous Conditions
- Positron-Emission Tomography
- Nuclear Medicine & Medical Imaging
- Neoplasm Staging
- Neoplasm Recurrence, Local
- Multimodal Imaging
- Lymphoma